1,818 followers
@DAgalliu @charlotterwayne “Secukinumab is a fully recombinant human immunoglobulin G (IgG)1 kappa monoclonal antibody (mAb) that directly inhibits IL-17A” https://t.co/6FAMhlIE3w
@DAgalliu @charlotterwayne “Secukinumab is a fully recombinant human immunoglobulin G (IgG)1 kappa monoclonal antibody (mAb) that directly inhibits IL-17A” https://t.co/6FAMhlIE3w
@NNwppn @DAgalliu @AgalliuLab @ColumbiaUniver Exciting! I wonder if it’s going to be similar to the IL-17A inhibitor for Ankylosing Spondylitis? This paper might be useful for you: https://t.co/6FAMhlIE3w
RT @RichAHoward: meta-analysis of IL-17a effectiveness and safety for #spondylitis. https://t.co/JIsXZMNefs
meta-analysis of IL-17a effectiveness and safety for #spondylitis. https://t.co/JIsXZMNefs